Sfoglia per Autore
Identification of genomic and proteomic signatures in lymphomas by inducible shRNA
2005-01-01 R Piva; E Pellegrino; M Mattioli; C Voena; C Conte; F Boccalatte; C Ambrogio; A Manazza; A Neri; R Chiarle; G Inghirami
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase
2005-01-01 AMBROGIO C; VOENA C; MANAZZA AD; PIVA R; RIERA L; BARBERIS L; COSTA C; TARONE G; DEFILIPPI P; HIRSCH E; ERBA EB; MOHAMMED S; JENSEN ON; PALESTRO G; INGHIRAMI G; CHIARLE R.
The Tyrosine Phosphatase SHP2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration.
2006-01-01 Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Inghirami G; Chiarle R.
Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
2006-01-01 PIVA R; CHIARLE R; MANAZZA AD; TAULLI R; SIMMONS W; AMBROGIO C; D'ESCAMARD V; PELLEGRINO E; PONZETTO C; PALESTRO G; INGHIRAMI G
Molecola perturbation of IFNγR2 internalization reinstates T cell sensitività to the IFNγ/STAT1 signaling pathway in vitro and in vivo. 5th
2007-01-01 Boselli D; Ragimbeau J; Orlando L; Cappello P; Bernabei P; Ambrogio C; Chiarle R; Pellegrini S; Giovarelli M; Novelli F.
Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gamma
2007-01-01 COSTA C; BARBERIS L; AMBROGIO C; MANAZZA AD; PATRUCCO E; AZZOLINO O; NEILSEN PO; CIRAOLO E; ALTRUDA F; PRESTWICH GD; CHIARLE R; WYMANN M; RIDLEY A; HIRSCH E
The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase
2007-01-01 BERTO G; CAMERA P; FUSCO C; IMARISIO S; AMBROGIO C; CHIARLE R; SILENGO L; DI CUNTO F
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration
2007-01-01 VOENA C; CONTE C; AMBROGIO C; BOERI ERBA E; BOCCALATTE F; MOHAMMED S; JENSEN ON; PALESTRO G; INGHIRAMI G; CHIARLE R
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination
2008-01-01 Chiarle R; Martinengo C; Mastini C; Ambrogio C; D’Escamard V; Forni G; Inghirami G
TTC3 protein inhibits neuronal differentiation through a RhoA dependent mechanism
2008-01-01 GE Berto; P Camera; C Ambrogio; F Di Cunto
TTC3 protein inhibits neuronal differentiation through RhoA and CITRON dependent mechanism
2008-01-01 GE Berto; P Camera; C Ambrogio; CS Dotti; F Di Cunto
The anaplastic lymphoma kinase in the pathogenesis of cancer
2008-01-01 R. CHIARLE; C. VOENA; C. AMBROGIO; R. PIVA; G. INGHIRAMI
Human Wrnip1 is localized in replication factories in a ubiquitin-binding zinc finger-dependent manner
2008-01-01 Crosetto N.; Bienko M.; Hibbert R.G.; Perica T.; Ambrogio C.; Kensche T.; Hofmann K.; Sixma T.K.; Dikic I.
The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation
2008-01-01 Ambrogio C; Voena C; Manazza AD; Martinengo C; Costa C; Kirchhausen T; Hirsch E; Inghirami G; Chiarle R.
Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin
2009-01-01 Barberis L; Pasquali C; Bertschy-Meier D; Cuccurullo A; Costa C; Ambrogio C; Vilbois F; Chiarle R; Wymann M; Altruda F; Rommel C; Hirsch E.
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells
2009-01-01 Ambrogio C; Martinengo C; Voena C; Tondat F; Riera L; di Celle PF; Inghirami G; Chiarle R.
MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling.
2010-01-01 Gonzalo P; Guadamillas MC; Hernández-Riquer MV; Pollán A; Grande-García A; Bartolomé RA; Vasanji A; Ambrogio C; Chiarle R; Teixidó J; Risteli J; Apte SS; del Pozo MA; Arroyo AG.
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.
2010-01-01 Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R.
Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes
2010-01-01 Boselli D; Ragimbeau J; Orlando L; Cappello P; Capello M; Ambrogio C; Chiarle R; Marsili G; Battistini A; Giovarelli M; Pellegrini S; Novelli F.
Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma.
2011-01-01 Di Paolo D; Ambrogio C; Pastorino F; Brignole C; Martinengo C; Carosio R; Loi M; Pagnan G; Emionite L; Cilli M; Ribatti D; Allen TM; Chiarle R; Ponzoni M; Perri P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Identification of genomic and proteomic signatures in lymphomas by inducible shRNA | 2005 | R Piva; E Pellegrino; M Mattioli; C Voena; C Conte; F Boccalatte; C Ambrogio; A Manazza; A Neri; R Chiarle; G Inghirami | |
| p130Cas mediates the transforming properties of the anaplastic lymphoma kinase | 2005 | AMBROGIO C; VOENA C; MANAZZA AD; PIVA R; RIERA L; BARBERIS L; COSTA C; TARONE G; DEFILIPPI P; HIRSCH E; ERBA EB; MOHAMMED S; JENSEN ON; PALESTRO G; INGHIRAMI G; CHIARLE R. | |
| The Tyrosine Phosphatase SHP2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration. | 2006 | Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Inghirami G; Chiarle R. | |
| Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas | 2006 | PIVA R; CHIARLE R; MANAZZA AD; TAULLI R; SIMMONS W; AMBROGIO C; D'ESCAMARD V; PELLEGRINO E; PONZETTO C; PALESTRO G; INGHIRAMI G | |
| Molecola perturbation of IFNγR2 internalization reinstates T cell sensitività to the IFNγ/STAT1 signaling pathway in vitro and in vivo. 5th | 2007 | Boselli D; Ragimbeau J; Orlando L; Cappello P; Bernabei P; Ambrogio C; Chiarle R; Pellegrini S; Giovarelli M; Novelli F. | |
| Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gamma | 2007 | COSTA C; BARBERIS L; AMBROGIO C; MANAZZA AD; PATRUCCO E; AZZOLINO O; NEILSEN PO; CIRAOLO E; ALTRUDA F; PRESTWICH GD; CHIARLE R; WYMANN M; RIDLEY A; HIRSCH E | |
| The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase | 2007 | BERTO G; CAMERA P; FUSCO C; IMARISIO S; AMBROGIO C; CHIARLE R; SILENGO L; DI CUNTO F | |
| The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration | 2007 | VOENA C; CONTE C; AMBROGIO C; BOERI ERBA E; BOCCALATTE F; MOHAMMED S; JENSEN ON; PALESTRO G; INGHIRAMI G; CHIARLE R | |
| The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination | 2008 | Chiarle R; Martinengo C; Mastini C; Ambrogio C; D’Escamard V; Forni G; Inghirami G | |
| TTC3 protein inhibits neuronal differentiation through a RhoA dependent mechanism | 2008 | GE Berto; P Camera; C Ambrogio; F Di Cunto | |
| TTC3 protein inhibits neuronal differentiation through RhoA and CITRON dependent mechanism | 2008 | GE Berto; P Camera; C Ambrogio; CS Dotti; F Di Cunto | |
| The anaplastic lymphoma kinase in the pathogenesis of cancer | 2008 | R. CHIARLE; C. VOENA; C. AMBROGIO; R. PIVA; G. INGHIRAMI | |
| Human Wrnip1 is localized in replication factories in a ubiquitin-binding zinc finger-dependent manner | 2008 | Crosetto N.; Bienko M.; Hibbert R.G.; Perica T.; Ambrogio C.; Kensche T.; Hofmann K.; Sixma T.K.; Dikic I. | |
| The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation | 2008 | Ambrogio C; Voena C; Manazza AD; Martinengo C; Costa C; Kirchhausen T; Hirsch E; Inghirami G; Chiarle R. | |
| Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin | 2009 | Barberis L; Pasquali C; Bertschy-Meier D; Cuccurullo A; Costa C; Ambrogio C; Vilbois F; Chiarle R; Wymann M; Altruda F; Rommel C; Hirsch E. | |
| NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells | 2009 | Ambrogio C; Martinengo C; Voena C; Tondat F; Riera L; di Celle PF; Inghirami G; Chiarle R. | |
| MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. | 2010 | Gonzalo P; Guadamillas MC; Hernández-Riquer MV; Pollán A; Grande-García A; Bartolomé RA; Vasanji A; Ambrogio C; Chiarle R; Teixidó J; Risteli J; Apte SS; del Pozo MA; Arroyo AG. | |
| Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. | 2010 | Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R. | |
| Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes | 2010 | Boselli D; Ragimbeau J; Orlando L; Cappello P; Capello M; Ambrogio C; Chiarle R; Marsili G; Battistini A; Giovarelli M; Pellegrini S; Novelli F. | |
| Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma. | 2011 | Di Paolo D; Ambrogio C; Pastorino F; Brignole C; Martinengo C; Carosio R; Loi M; Pagnan G; Emionite L; Cilli M; Ribatti D; Allen TM; Chiarle R; Ponzoni M; Perri P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile